English to Serbian Law/Patents Medical: Pharmaceuticals Treatment of muscular dys

At the 6-month endpoint post treatment, muscle from the treated mice were evaluated for SCGA protein expression, histological rescue, and functional improvement. All three doses showed robust protein expression of α-SG at the sarcolemma, improved histopathology, increased locomotor activity and specific-force generation, protection against eccentric force loss, and reduced serum CK compared with controls.